Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Diovan/Co-Diovan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.

Novartis pays $422m to settle probe

blood-pressure medications Diovan, Exforge and Tekturna; the acromegaly treatment Sandostatin; and the irritable bowel syndrome drug Zelnorm.

Changing the record

My diovan.com experience kicked off with a picture of an old bloke straddling a surf board. ... me that the surfer man is not an actual Diovan or Diovan HCT patient.

Novartis' net income up 15 per cent for Q2

Other strong performing products included Diovan (valsartan) for high blood pressure, which made $1.6bn and Gleevec/Glivec (imatinib mesylate) for chronic myelogenous leukemia, which made $1.1bn.

ARBs link to cancer risk to be investigated

Other drugs in the class include Merck's Cozaar (losartan), AstraZeneca's Atacand (candesartan cilexetil), Novartis' Diovan (valsartan), sanofi-aventis and Bristol-Myers Squibb's Avapro (irbesartan), Daiichi Sankyo's Benicar

Novartis medicines approved in Japan

Exforge has been approved as a single-pill combination of two treatments for high blood pressure: Diovan (valsartan) and amlodipine.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics